Castle Biosciences, Inc. (CSTL)
35.61
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 05, 13:40
Castle Biosciences Profit Margin (Quarterly) : -1.99% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.99% |
| March 31, 2026 | -17.35% |
| December 31, 2025 | -2.68% |
| September 30, 2025 | -0.60% |
| June 30, 2025 | 5.25% |
| March 31, 2025 | -29.38% |
| December 31, 2024 | 11.11% |
| September 30, 2024 | 2.65% |
| June 30, 2024 | 10.25% |
| March 31, 2024 | -3.47% |
| December 31, 2023 | -3.90% |
| September 30, 2023 | -11.23% |
| June 30, 2023 | -37.45% |
| March 31, 2023 | -69.47% |
| December 31, 2022 | -53.78% |
| September 30, 2022 | -54.71% |
| June 30, 2022 | -4.73% |
| Date | Value |
|---|---|
| March 31, 2022 | -91.70% |
| December 31, 2021 | -25.68% |
| September 30, 2021 | -50.23% |
| June 30, 2021 | -38.63% |
| March 31, 2021 | -18.76% |
| December 31, 2020 | -28.26% |
| September 30, 2020 | -30.16% |
| June 30, 2020 | -10.82% |
| March 31, 2020 | 3.27% |
| December 31, 2019 | 11.65% |
| September 30, 2019 | 39.59% |
| June 30, 2019 | -11.82% |
| March 31, 2019 | -15.58% |
| September 30, 2018 | -92.95% |
| June 30, 2018 | -79.28% |
| March 31, 2018 | -99.23% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| RadNet, Inc. | 3.25% |
| Lumexa Imaging Holdings, Inc. | 1.04% |
| Quest Diagnostics, Inc. | 10.94% |
| Labcorp Holdings, Inc. | 8.02% |
| OPKO Health, Inc. | -5.14% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -4.18% |
| Return on Assets | -3.44% |
| Return on Invested Capital | -3.87% |
| Gross Profit Margin (Quarterly) | 74.29% |
| Operating Margin (Quarterly) | -2.96% |
| Return on Net Operating Assets | -7.36% |